1 Shi, Y. J. et al. Quality assessment of global lung cancer screening guidelines and consensus. Zhong hua liu xing bing xue za zhi42, 241-247, doi:10.3760/cma.j.cn112338-20200806-01035 (2021).
2 Schegoleva, A. A. et al. Prognosis of Different Types of Non-Small Cell Lung Cancer Progression: Current State and Perspectives. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology55, 29-48, doi:10.33594/000000340 (2021).
3 Wang, W. et al. Efficacy of docetaxel plus carboplatin combination chemotherapy for advanced non-small cell lung cancer. Zhong guo fei ai za zhi 10, 316-319, doi:10.3779/j.issn.1009-3419.2007.04.13 (2007).
4 Pothipor, C., Aroonyadet, N., Bamrungsap, S., Jakmunee, J. & Ounnunkad, K. A highly sensitive electrochemical microRNA-21 biosensor based on intercalating methylene blue signal amplification and a highly dispersed gold nanoparticles/graphene/polypyrrole composite. The Analyst, doi:10.1039/d1an00116g (2021).
5 Miao, H. et al. LncRNA TP73-AS1 enhances the malignant properties of pancreatic ductal adenocarcinoma by increasing MMP14 expression through miRNA -200a sponging. Journal of cellular and molecular medicine, doi:10.1111/jcmm.16425 (2021).
6 Yan, Y. et al. CCMAlnc Promotes the Malignance of Colorectal Cancer by Modulating the Interaction Between miR-5001-5p and Its Target mRNA. Frontiers in cell and developmental biology8, 566932, doi:10.3389/fcell.2020.566932 (2020).
7 Yuan, C. et al. Network pharmacology and molecular docking reveal the mechanism of Scopoletin against non-small cell lung cancer. Life sciences270, 119105, doi:10.1016/j.lfs.2021.119105 (2021).
8 Zang, X. et al. Dual-targeting tumor cells and tumor associated macrophages with lipid coated calcium zoledronate for enhanced lung cancer chemoimmunotherapy. International journal of pharmaceutics594, 120174, doi:10.1016/j.ijpharm.2020.120174 (2021).
9 Weissferdt, A. et al. Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy. Clinical lung cancer21, 341-348, doi:10.1016/j.cllc.2019.11.003 (2020).
10 Liu, J. & Wang, X. Early recognition of tomato gray leaf spot disease based on MobileNetv2-YOLOv3 model. Plant methods16, 83, doi:10.1186/s13007-020-00624-2 (2020).
11 Marquis, C. et al. Chromosomally unstable tumor cells specifically require KIF18A for proliferation. Nature communications12, 1213, doi:10.1038/s41467-021-21447-2 (2021).
12 Passaro, A. et al. Clinical features affecting survival in metastatic NSCLC treated with immunotherapy: A critical review of published data. Cancer treatment reviews89, 102085, doi:10.1016/j.ctrv.2020.102085 (2020).
13 Chen, S. & Wu, S. Identifying Lung Cancer Risk Factors in the Elderly Using Deep Neural Networks: Quantitative Analysis of Web-Based Survey Data. Journal of medical Internet research22, e17695, doi:10.2196/17695 (2020).
14 Werner, A. et al. Contribution of natural antisense transcription to an endogenous siRNA signature in human cells. BMC genomics15, 19, doi:10.1186/1471-2164-15-19 (2014).
15 Ayati, S. H. et al. Regulatory effects of berberine on microRNome in Cancer and other conditions. Critical reviews in oncology/hematology116, 147-158, doi:10.1016/j.critrevonc.2017.05.008 (2017).
16 Cardillo, N. et al. Identification of Novel lncRNAs in Ovarian Cancer and Their Impact on Overall Survival. International journal of molecular sciences22, doi:10.3390/ijms22031079 (2021).
17 Duan, A. et al. Chromatin architecture reveals cell type-specific target genes for kidney disease risk variants. BMC biology19, 38, doi:10.1186/s12915-021-00977-7 (2021).
18 Barrett, T. et al. NCBI GEO: archive for functional genomics data sets--update. Nucleic acids research41, D991-995, doi:10.1093/nar/gks1193 (2013).
19 Zhang, X. et al. Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data. Journal of cellular biochemistry120, 17898-17911, doi:10.1002/jcb.29058 (2019).
20 Li, L. et al. Upregulation of circular RNA circ_0001721 predicts unfavorable prognosis in osteosarcoma and facilitates cell progression via sponging miR-569 and miR-599. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie109, 226-232, doi:10.1016/j.biopha.2018.10.072 (2019).
21 Szklarczyk, D. et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic acids research47, D607-d613, doi:10.1093/nar/gky1131 (2019).
22 Sun, Q. et al. Differential Expression and Bioinformatics Analysis of circRNA in Non-small Cell Lung Cancer. Frontiers in genetics11, 586814, doi:10.3389/fgene.2020.586814 (2020).
23 Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols4, 44-57, doi:10.1038/nprot.2008.211 (2009).
24 Nagy, Á., Lánczky, A., Menyhárt, O. & Győrffy, B. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Scientific reports8, 9227, doi:10.1038/s41598-018-27521-y (2018).
25 Tang, Z. et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic acids research45, W98-w102, doi:10.1093/nar/gkx247 (2017).
26 Liu, Z. et al. A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer. Journal of cellular and molecular medicine24, 12444-12456, doi:10.1111/jcmm.15762 (2020).
27 Huang, H. Y. et al. miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database. Nucleic acids research48, D148-d154, doi:10.1093/nar/gkz896 (2020).
28 Sticht, C., De La Torre, C., Parveen, A. & Gretz, N. miRWalk: An online resource for prediction of microRNA binding sites. PloS one13, e0206239, doi:10.1371/journal.pone.0206239 (2018).
29 Zheng, Y. et al. lnCAR: A Comprehensive Resource for lncRNAs from Cancer Arrays. Cancer research79, 2076-2083, doi:10.1158/0008-5472.can-18-2169 (2019).
30 Ren, L., Guo, D., Wan, X. & Qu, R. EYA2 upregulates miR-93 to promote tumorigenesis of breast cancer by targeting and inhibiting the STING signaling pathway. Carcinogenesis, doi:10.1093/carcin/bgab001 (2021).